Premium IOL Adoption Is a Decision Problem, Not a Sales Problem
When premium adoption underperforms, the instinct is to look at the technology, the pricing, or the sales skills of the team. In most cases, none of these is the real constraint.
Oleksii Sologub
Strategic Advisor in Premium IOL Adoption
Most private eye surgery clinics already have what they believe they need: experienced surgeons, modern diagnostics, and a full range of premium IOL options. Yet premium adoption remains inconsistent. One surgeon converts a high proportion of consultations; another, with identical tools and pricing, does not. The technology is the same. The price is the same. The patient population is broadly the same. What differs is the decision journey.
The technology is rarely the constraint
Premium IOL technologies are, by any reasonable measure, mature. The optical designs are sophisticated, the clinical evidence is substantial, and the patient benefit — reduced spectacle dependence, improved range of vision — is real and well documented. When a clinic has access to these technologies and still sees low adoption, the problem is not that the technology is weak. It is that the patient never arrives at a clear, confident decision to choose it.
Where decisions actually break down
A patient deciding on a premium IOL is not making a purely clinical choice. They are weighing cost against a future they can only partially imagine, balancing fear of surgery against a desire for a better quality of life, and trying to understand trade-offs that are genuinely complex. When the consultation presents technical information without connecting it to that patient's real life, the patient does not reject the option — they simply never commit to it.
The result is not a dramatic failure. It is a quiet drift toward the default. The patient chooses the familiar option, or postpones the decision, or agrees without conviction and later reports dissatisfaction. None of these outcomes is visible as a single failure. They show up as an aggregate: inconsistent adoption, compressed margin, and a team that cannot explain why.
The strategic opportunity
Reframing premium adoption as a decision problem changes what a clinic pays attention to. Instead of asking how to sell more premium lenses, the question becomes: how does a patient move from 'I need cataract surgery' to 'I understand my options and I am confident in my choice'? That is a pathway that can be designed, structured, and made consistent — not left to the communication skill of whichever surgeon happens to be in the room.